US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% SDEV $7.48 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00%
FinancialContent

Articles published by Cerecin

News headline image
Cerecin received US FDA clearance to study CER-0001 under an Investigational New Drug (IND) application for Infantile Spasms
From Cerecin
Via GlobeNewswire
News headline image
Cerecin Announces Abstract on New Infantile Spasms Data Accepted for Oral Presentation at the International League Against Epilepsy EME Congress 2022
From Cerecin
Via GlobeNewswire
News headline image
Results of Pilot Study of CER-0001 in Migraine support advancement into a pivotal global Phase 2/3 study
From Cerecin
Via GlobeNewswire
News headline image
Cerecin appoints Dr. Marc Cantillon as Chief Medical Officer
From Cerecin
Via GlobeNewswire
News headline image
Cerecin closes Series IIB financing to advance CER-0001 clinical programs and build pipeline in neuro-metabolism drug development
From Cerecin
Via GlobeNewswire
Tickers NSRGY